Ruxolitinib in Thrombocythemia and Polycythemia Vera

NCT04644211 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Essential Thrombocythemia
Polycythemia Vera

Interventions

DRUG: Ruxolitinib

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]